What is NDC 71335-2113?

71335-2113 is the product NDC for Doxycycline Hyclate, Doxycycline hyclate 100 mg/1 tablet, listed with the FDA by Bryant Ranch Prepack. It has 9 package NDCs, shown above in 10- and 11-digit form.

Bryant Ranch Prepack, NDC labeler code 71335. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Doxycycline Hyclate?

175 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Doxycycline Hyclate NDC 71335-2113

NDC codes

FDA NDC Directory

Product NDC (as listed)71335-2113Labeler and product segments. Claims need a package NDC.

Product NDC at billing width71335-2113Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
71335-2113-1	7133521130171335211301	20 TABLET in 1 BOTTLE (71335-2113-1)Marketed from Jan 31, 2025
71335-2113-2	7133521130271335211302	30 TABLET in 1 BOTTLE (71335-2113-2)Marketed from Sep 7, 2022
71335-2113-3	7133521130371335211303	50 TABLET in 1 BOTTLE (71335-2113-3)Marketed from Sep 7, 2022
71335-2113-4	7133521130471335211304	14 TABLET in 1 BOTTLE (71335-2113-4)Marketed from Jan 31, 2025
71335-2113-5	7133521130571335211305	40 TABLET in 1 BOTTLE (71335-2113-5)Marketed from Jan 31, 2025
71335-2113-6	7133521130671335211306	60 TABLET in 1 BOTTLE (71335-2113-6)Marketed from Jan 31, 2025
71335-2113-7	7133521130771335211307	28 TABLET in 1 BOTTLE (71335-2113-7)Marketed from Jan 31, 2025
71335-2113-8	7133521130871335211308	10 TABLET in 1 BOTTLE (71335-2113-8)Marketed from Jan 31, 2025
71335-2113-9	7133521130971335211309	6 TABLET in 1 BOTTLE (71335-2113-9)Marketed from Jan 31, 2025

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Doxycycline Hyclate
Generic name (nonproprietary): doxycycline hyclate
Active ingredients: Doxycycline hyclate — 100 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Bryant Ranch PrepackNDC labeler code 71335
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 207773
Marketing start: Mar 14, 2019
Listing expires: Dec 31, 2026
Other FDA classes: Tetracyclines (Chemical structure)
Identifiers: Product ID 71335-2113_2a8fc1ec-e0ab-4418-ac20-93d68fa4a5fcSPL ID 2a8fc1ec-e0ab-4418-ac20-93d68fa4a5fcSPL set ID 5b4390ed-a0ec-4ef8-864c-8a33a83653f9RxCUI 1650143UNII 19XTS3T51U
Pharmacologic class: Tetracycline-class Drug

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N471335211301 followed by a unit qualifier and the quantity

Package 71335-2113-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 31, 2025.

Indications (excerpt from the label)

INDICATIONS AND USAGE To reduce the development of drug-resistant bacteria and maintain effectiveness of doxycycline hyclate tablets and other antibacterial drugs, doxycycline hyclate tablets should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. Treatment Doxycycline hyclate tablets are indicated for the treatment of the following infections: Rocky Mountain spott…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 71335-2113

What is NDC 71335-2113?: 71335-2113 is the product NDC for Doxycycline Hyclate, Doxycycline hyclate 100 mg/1 tablet, listed with the FDA by Bryant Ranch Prepack. It has 9 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Doxycycline Hyclate.
What is the active ingredient?: Doxycycline hyclate.
Who is the labeler?: Bryant Ranch Prepack, NDC labeler code 71335. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Doxycycline Hyclate?: 175 other product NDCs are listed under this name. See all Doxycycline Hyclate NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Doxycycline Hyclate NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Doxycycline Hyclate	Doxycycline hyclate 100 mg/1	CapsuleOral	Unit Dose Solutions, Inc.	87441-029	87441-0029-01
Doxycycline Hyclate	Doxycycline hyclate 100 mg/1	CapsuleOral	Coupler LLC	67046-0135	67046-0135-03
Doxycycline Hyclate	Doxycycline hyclate 50 mg/1	TabletOral	Strides Pharma Science Limited	64380-225	64380-0225-01
Doxycycline Hyclate	Doxycycline hyclate 100 mg/1	TabletOral	Strides Pharma Science Limited	64380-226	64380-0226-02
Doxycycline Hyclate	Doxycycline hyclate 100 mg/1	CapsuleOral	REMEDYREPACK INC.	70518-4658	70518-4658-00
Doxycycline Hyclate	Doxycycline hyclate 50 mg/1	CapsuleOral	Zhejiang Yongtai Pharmaceutical Co., Ltd	69434-016	69434-0016-0369434-0016-06
Doxycycline Hyclate	Doxycycline hyclate 100 mg/1	CapsuleOral	Zhejiang Yongtai Pharmaceutical Co., Ltd	69434-017	69434-0017-0369434-0017-06
Doxycycline Hyclate	Doxycycline hyclate 100 mg/1	TabletOral	REMEDYREPACK INC.	70518-4544	70518-4544-00
Doxycycline Hyclate	Doxycycline hyclate 100 mg/1	CapsuleOral	Macleods Pharmaceuticals Limited	33342-386	33342-0386-0833342-0386-1233342-0386-15
Doxycycline Hyclate	Doxycycline hyclate 100 mg/1	TabletOral	Macleods Pharmaceuticals Limited	33342-392	33342-0392-0533342-0392-0833342-0392-11+2 more

All 176 Doxycycline Hyclate NDCs

Other NDCs under ANDA 207773

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 207773
Product	Strength	Form · route	Labeler	Product NDC
Doxycycline Hyclate	Doxycycline hyclate 100 mg/1	TabletOral	NCS HealthCare of KY, LLC dba Vangard Labs	0615-8529
Doxycycline Hyclate	Doxycycline hyclate 100 mg/1	TabletOral	RedPharm Drug, Inc.	67296-1431
Doxycycline hyclate	Doxycycline hyclate 100 mg/1	TabletOral	Zydus Lifesciences Limited	70771-1104
Doxycycline Hyclate	Doxycycline hyclate 100 mg/1	TabletOral	Viona Pharmaceuticals Inc	72578-001